Jay Rughani

Jay Rughani

Bio + Health Investing Team

About

Jay Rughani is a partner at Andreessen Horowitz, where he leads investments in health technology companies.

Over the past 8 years, Jay has helped to build the a16z Bio + Health practice and lead a16z’s investments in numerous ambitious companies, including Alchemy, Alleviate, Aradigm, Backbone, Counsel, Ferry, Gravity, Inductive, Komodo, Leona, Midstream, Orchestra, Pearl, Prosper, Tennr, Thatch, Thyme, Turquoise, and Valar.

Prior to joining a16z in 2018, Jay was an early team member at Flatiron, an electronic health record and real-world evidence company acquired by Roche for ~$2B. There, he helped to build some of the company’s first healthcare software and data products and later led numerous commercial partnerships through the company’s period of hypergrowth. Before Flatiron, he consulted for large healthcare and technology companies around the world at Deloitte, worked at Dealermatch (a seed-stage B2B marketplace later acquired by Cox Enterprises), and co-founded an unsuccessful startup with his college roommate.

Jay graduated from Emory University with a degree in Mathematics & Economics and grew up mostly in Tampa Bay, FL, apart from a three-year stint in boarding school in London, UK.

Latest Content by Jay

General

Investing in Prosper AI

Bio + Health

Infinite Healthcare: What’s It Worth?

Bio + Health

Healthcare 2026: AI Doctors, GLP-1s, and Insurance Defection

Bio + Health

AI Doctors, GLP-1s, and Insurance Defection

Bio + Health

Investing in Leona

Bio + Health

Investing in Aradigm

Bio + Health

Investing in Counsel Health

Bio + Health

Value-Based Oncology at Scale: Inside Thyme Care

load more

Expert News by a16z

We have built a network of experts who are deeply rooted in technology and how it’s shaping our future. Subscribe to our newsletters to receive their perspectives.